Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,748 GBX | +0.81% | +4.24% | +20.26% |
05-06 | GSK : UBS remains its Buy rating | ZD |
05-03 | GSK : DZ Bank remains Neutral | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.26% | 88.87B | |
+31.52% | 690B | |
+24.50% | 546B | |
-5.21% | 358B | |
+17.02% | 323B | |
+5.01% | 287B | |
+13.98% | 235B | |
+5.17% | 199B | |
-9.94% | 195B | |
+3.98% | 161B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- GlaxoSmithKline Names Nonexecutive Chair Designate of New Consumer Unit